Here is a summary of a 2021 study into the efficacy and safety of using a traditional Chinese medicine (TCM) formula in patients with Sjogren's syndrome (SS).
More than 90% of patients with primary SS in Taiwan are treated by TCM doctors but the effectiveness of TCM for patients with pSS in a clinical setting is unknown.
INTRODUCTION
Current therapies for SS in Western medicine are limited. The purpose of this clinical study was to explore the efficacy and safety of using a traditional Chinese medicine (TCM) formula on patients with primary SS.
METHODS
A 12-week, randomized, double-blinded, placebo-controlled clinical trial at Chung Shan Medical University Hospital.
42 patients with SS between the ages of 20 and 80 years who met the classification criteria of the American and European Consensus Group were included.
Patients were randomly assigned to the TCM treatment group or placebo group (ratio of 2:1).
TCM group were treated with 6 g of Gan-Lu-Yin granules after breakfast and 6 g of Jia-Wei-Xiao-Yao-San combined with 1 g of Suan-Zao-Ren-Tang and 1 g of Ye-Jiao-Teng every night after dinner.
No significant difference was observed between the two groups.
Sleep duration in the Pittsburgh Sleep Quality Score (PSQI) was −0.61, which was an improvement of more than the −0.21 compared with the placebo group (P = 0.914).
CONCLUSION
The results did not show that the use of the TCM formula was effective for treating patients with Sjogren's syndrome. However, the PSQI scores indicated that this formula could both prolong patient sleep duration and decrease the blood pressure of patients.
Comments
Post a Comment